VEGFA and age-related macular degeneration: Overall, 8.3% (n = 945) of patients on lipid-lowering medications had a diagnosis code for exudative AMD or a procedural code for anti-VEGF injections following non-exudative AMD diagnosis, compared to 7.9% (n = 2,483) of patients who did not take lipid-lowering medications (p = .099).